Video Experimental Relacionado
Updated: May 16, 2026
09:11
Assays for Validating Histone Acetyltransferase Inhibitors
Published on: August 6, 2020
CKIP-1 inhibe la hipertrofia cardíaca mediante la regulación de la fosforilación de la histona desacetilasa de clase
Shukuan Ling1, Qiao Sun, Yuheng Li
1State Key Laboratory of Space Medicine Fundamentals and Application, China Astronaut Research and Training Center, Haidian District, Beiqing Rd, Beijing, China.
Circulation
|November 16, 2012
Resumen
La proteína-1 de interacción con la caseína quinasa-2 (CKIP-1) inhibe la hipertrofia cardíaca. La deficiencia de CKIP-1 exacerba el agrandamiento del corazón, mientras que su sobreexpresión protege contra él mediante la regulación de la desfosforilación HDAC4.
Área de la Ciencia:
- Biología Cardiovascular Biología Cardiovascular
- Cardiología Molecular Cardiología Molecular
- Regulación genética Reglamento genético.
Sus antecedentes:
- La hipertrofia cardíaca y la remodelación son precursores de la insuficiencia cardíaca.
- La proteína-1 de interacción con la caseína quinasa-2 (CKIP-1) está implicada en el crecimiento y muerte celular.
- El papel de CKIP-1 en la fisiología cardíaca era previamente indefinido.
Objetivo del estudio:
- Para investigar la función fisiológica de CKIP-1 en el corazón.
- Determinar el papel de CKIP-1 en la hipertrofia cardíaca y la remodelación patológica.
Principales métodos:
- Ecocardiografía e histología en ratones transgénicos y con deficiencia de CKIP-1.
- Pruebas de extracción de GST y ensayos de coinmunoprecipitación.
- Análisis de las interacciones proteína-proteína y la actividad enzimática.
Principales resultados:
- Los ratones con deficiencia de CKIP-1 mostraron hipertrofia cardíaca espontánea e hipersensibilidad a la sobrecarga de presión.
- La sobreexpresión de CKIP-1 confirió resistencia a la hipertrofia cardíaca inducida por sobrecarga de presión.
- CKIP-1 interactúa con la histona desacetilasa 4 (HDAC4), inhibiendo su actividad transcripcional y promoviendo su desfosforilación a través de la fosfatasa 2A.
Conclusiones:
- CKIP-1 actúa como un inhibidor crucial de la hipertrofia cardíaca.
- CKIP-1 suprime la hipertrofia cardíaca al mejorar la desfosforilación de HDAC4 a través del reclutamiento de la proteína fosfatasa 2A.
- CKIP-1 regula la expresión génica fetal, ofreciendo un nuevo objetivo terapéutico para la insuficiencia cardíaca.
Más Videos Relacionados
08:00Enhancing the Engraftment of Human Induced Pluripotent Stem Cell-derived Cardiomyocytes via a Transient Inhibition of Rho Kinase Activity
Published on: July 10, 2019
05:38Generation and Expansion of Human Cardiomyocytes from Patient Peripheral Blood Mononuclear Cells
Published on: February 12, 2021
Videos de Conceptos Relacionados
01:26Cellular Adaptation II: Hypertrophy
Hypertrophy is the increase in the size of individual cells, resulting in the enlargement of a tissue or organ. Unlike hyperplasia, which involves an increase in cell number, hypertrophy is characterized by an increase in cell volume. This process often occurs in response to higher functional demand or hormonal stimulation, leading to the production of more structural proteins and organelles, thereby enhancing the cells' work capacity.There are two primary types of hypertrophy: physiological...
01:29Cardiomyopathy III: Hypertrophic Cardiomyopathy
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
01:25cAMP-dependent Protein Kinase Pathways
Cyclic Adenosine Monophosphate (cAMP) is an essential second messenger that activates protein kinase A (PKA) and regulates various biological processes. A single epinephrine molecule binds to GPCR and activates several heterotrimeric G proteins, each stimulating multiple adenylyl cyclase, amplifying the signal, and synthesizing large numbers of cAMP molecules. Small changes in cAMP concentration affect PKA activity. The binding of four cAMP molecules induces a conformational change in PKA,...
01:20The JAK-STAT Signaling Pathway
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
02:34Inhibition of Cdk Activity
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
01:32Chromatin Modification in iPS Cells
Chromatin modification alters gene expression; therefore, scientists can add histone-modifying enzymes, histone variants, and chromatin remodeling complexes to somatic cells to aid reprogramming into pluripotent stem (iPS) cells.
Compact chromatin makes reprogramming difficult. Enzymes, such as histone demethylases and acetyltransferases, are often added during reprogramming to loosen the chromatin, making the DNA more accessible to transcription factors. Molecules that inhibit histone...
Compact chromatin makes reprogramming difficult. Enzymes, such as histone demethylases and acetyltransferases, are often added during reprogramming to loosen the chromatin, making the DNA more accessible to transcription factors. Molecules that inhibit histone...